ANTHRIVIG, created in 2010 (United States), from 22 sister brands and 4958 competing brands. The ANTHRIVIG brand is owned by Emergent Biosolutions, a company listed in New York. ANTHRIVIG belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
Emergent Biosolutions
(ANTHRIVIG)
over 5 years*
USD 0.13